Phentolamine mesilate structure
|
Common Name | Phentolamine mesilate | ||
|---|---|---|---|---|
| CAS Number | 65-28-1 | Molecular Weight | 377.458 | |
| Density | N/A | Boiling Point | 551ºC at 760 mmHg | |
| Molecular Formula | C18H23N3O4S | Melting Point | 180-182 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 287ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of Phentolamine mesilatePhentolamine mesylate is a competitive, reversible α-adrenoceptor antagonist with an IC50 between 5 and 30 nM. |
| Name | Phentolamine Mesylate |
|---|---|
| Synonym | More Synonyms |
| Description | Phentolamine mesylate is a competitive, reversible α-adrenoceptor antagonist with an IC50 between 5 and 30 nM. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 551ºC at 760 mmHg |
|---|---|
| Melting Point | 180-182 °C(lit.) |
| Molecular Formula | C18H23N3O4S |
| Molecular Weight | 377.458 |
| Flash Point | 287ºC |
| Exact Mass | 377.140930 |
| PSA | 110.61000 |
| LogP | 3.18960 |
| Storage condition | Refrigerator |
| Stability | Aq. Solutions Cannot be Stored |
| Water Solubility | 50 MG/ML |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 + H312 + H332-H315-H319-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R20/21/22;R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | 3249 |
| WGK Germany | 3 |
| RTECS | SL5430000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2933290090 |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Chem. Res. Toxicol. 23 , 1215-22, (2010) Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ... |
|
|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Drug Metab. Dispos. 38 , 2302-8, (2010) Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti... |
|
|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
| EINECS 200-604-6 |
| Phenol, 3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-, methanesulfonate (1:1) (salt) |
| Phentolamine methanesulfonate salt |
| 2-(m-Hydroxy-N-p-tolylanilinomethyl)-2-imidazoline Monomethanesulfonate (Salt) |
| 3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol methanesulfonate (salt) |
| Phentolamine methanesulfonate |
| Phentolamine methanesulphonate |
| Phentolamine mesylate |
| 2-(N'-p-Tolyl-N'-m-hydroxyphenylaminomethyl)-2-imidazoline Monomethanesulfonate (Salt) |
| Methansulfonsäure--3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]benzolol(1:1) |
| 2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline Monomethanesulfonate (Salt) |
| Phentolamine mesilate |
| Regitine |
| 3-[(4,5-Dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol methanesulfonate (1:1) |
| 3-[[(4,5-Dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]phenol Monomethanesulfonate (Salt) |
| Rogitine |
| MFCD00134201 |
| Phentolamine (mesylate) |